Dopamine D2 Receptor Antagonists
"Dopamine D2 Receptor Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds and drugs that bind to and inhibit or block the activation of DOPAMINE D2 RECEPTORS.
| Descriptor ID |
D065127
|
| MeSH Number(s) |
D27.505.519.625.150.175.500 D27.505.696.577.150.175.500
|
| Concept/Terms |
Dopamine D2 Receptor Antagonists- Dopamine D2 Receptor Antagonists
- Receptor Antagonists, Dopamine D2
- Dopamine D2 Antagonists
- Antagonists, Dopamine D2
- D2 Antagonists, Dopamine
|
Below are MeSH descriptors whose meaning is more general than "Dopamine D2 Receptor Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Dopamine D2 Receptor Antagonists".
This graph shows the total number of publications written about "Dopamine D2 Receptor Antagonists" by people in this website by year, and whether "Dopamine D2 Receptor Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
| 2012 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Dopamine D2 Receptor Antagonists" by people in Profiles.
-
Dopamine Receptor D5 is a Modulator of Tumor Response to Dopamine Receptor D2 Antagonism. Clin Cancer Res. 2019 04 01; 25(7):2305-2313.
-
Dopamine D2/3 receptor antagonism reduces activity-based anorexia. Transl Psychiatry. 2015 Aug 04; 5:e613.
-
A role for dopamine-mediated learning in the pathophysiology and treatment of Parkinson's disease. Cell Rep. 2012 Dec 27; 2(6):1747-61.
-
D2 dopamine receptor subtype-mediated hyperactivity and amphetamine responses in a model of ADHD. Neurobiol Dis. 2010 Jan; 37(1):228-36.
-
Dopamine D2/D3 receptors play a specific role in the reversal of a learned visual discrimination in monkeys. Neuropsychopharmacology. 2007 Oct; 32(10):2125-34.
-
Distinct temporal phases in the behavioral pharmacology of LSD: dopamine D2 receptor-mediated effects in the rat and implications for psychosis. Psychopharmacology (Berl). 2005 Jul; 180(3):427-35.
-
Analysis of neuroleptic binding affinities and potencies for the different human D2 dopamine receptor missense variants. Pharmacogenetics. 1999 Feb; 9(1):17-23.
-
Antagonist binding characteristics of the Ser311-->Cys variant of human dopamine D2 receptor in vivo and in vitro. Biochem Biophys Res Commun. 1997 Mar 06; 232(1):143-6.